Medical Science News

RSS
Researchers overturn the prevailing theory for colorectal tumor initiation

Researchers overturn the prevailing theory for colorectal tumor initiation

Novel method creates antibody-peptide inhibitor conjugates with enhanced therapeutic efficacy

Novel method creates antibody-peptide inhibitor conjugates with enhanced therapeutic efficacy

Study reveals new link between high temperature exposure and sphingolipid metabolism in obesity

Study reveals new link between high temperature exposure and sphingolipid metabolism in obesity

Proline-based nano cages offer targeted drug delivery, limit side effects of chemotherapy

Proline-based nano cages offer targeted drug delivery, limit side effects of chemotherapy

Study links low oxytocin levels to symptoms of polycystic ovary syndrome

Study links low oxytocin levels to symptoms of polycystic ovary syndrome

Microplastics: Invisible to the eye but severely harmful to pregnancy and metabolic outcomes

Microplastics: Invisible to the eye but severely harmful to pregnancy and metabolic outcomes

Heart healthy behaviors may slow biological aging, research shows

Heart healthy behaviors may slow biological aging, research shows

Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing

Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing

Evaluating the efficacy of harmol in treating herpes simplex virus-induced keratitis

Evaluating the efficacy of harmol in treating herpes simplex virus-induced keratitis

GLP-1 receptor agonists effective for weight loss in obesity without diabetes

GLP-1 receptor agonists effective for weight loss in obesity without diabetes

RNAConnect, Inc. formally launches to drive RNA analysis

RNAConnect, Inc. formally launches to drive RNA analysis

Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics

Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics

Study finds Plexin-B1 could be key to Alzheimer’s treatment, enhancing glial cell response

Study finds Plexin-B1 could be key to Alzheimer’s treatment, enhancing glial cell response

Huge health and climate benefits of replacing old diesel school buses with electric in the United States

Huge health and climate benefits of replacing old diesel school buses with electric in the United States

Metabolic cell death pathways could be novel therapeutic targets in cancer treatment

Metabolic cell death pathways could be novel therapeutic targets in cancer treatment

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC

New AI model Dev-ResNet accurately monitors embryonic development in real-time

New AI model Dev-ResNet accurately monitors embryonic development in real-time

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

Study highlights a dietary strategy for health improvement and weight management

Study highlights a dietary strategy for health improvement and weight management

Tattoos linked to higher risk of malignant lymphoma, study finds

Tattoos linked to higher risk of malignant lymphoma, study finds

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.